Asymchem's Enzyme-Powered Innovations In Manufacturing

Enzyme technology is rapidly reshaping how complex medicines are discovered and manufactured. This video explores how more than a decade of focused investment in enzyme engineering has enabled precision, efficiency, and scalability across modalities ranging from small molecules to peptides and oligonucleotides. By combining artificial intelligence with automated, cell-free systems, enzyme design timelines have been significantly compressed, strengthening the foundation of modern biocatalysis.

The discussion highlights how these capabilities now support increasingly complex applications, including commercial-scale production of therapeutic enzymes and recombinase proteins. Viewers also gain insight into a newly developed continuous-flow SNRA platform, built on the same principles of enzyme engineering, automation, and continuous manufacturing, and how it is expanding the boundaries of what enzyme-driven processes can achieve.

Looking ahead, the video underscores the growing role of enzyme-powered manufacturing in the future of medicine, with synthetic biology and intelligent automation accelerating the path to next-generation therapies that are faster, more sustainable, and designed for global impact. Watch the full video to explore how these technologies are redefining biomanufacturing.